MTCH
46
-2
NWS
84
20
IFF
42
-2
AMP
61
-2
TJX
51
7
DIS
62
-2
VRTX
45
2
HRB
61
9
AEP
59
3
ROST
41
-19
STZ
30
-3
TDC
59
-3
IPG
42
11
IVZ
46
-2
GM
69
-3
GOOGL
58
-4
M
34
-5
FRT
51
-2
NTAP
56
-5
RHI
25
-3
MTCH
46
-2
NWS
84
20
IFF
42
-2
AMP
61
-2
TJX
51
7
DIS
62
-2
VRTX
45
2
HRB
61
9
AEP
59
3
ROST
41
-19
STZ
30
-3
TDC
59
-3
IPG
42
11
IVZ
46
-2
GM
69
-3
GOOGL
58
-4
M
34
-5
FRT
51
-2
NTAP
56
-5
RHI
25
-3
Financhill
Back

CytomX Therapeutics Stock Predictions

The Future of Housing Is Being Built Now

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Buy
58

CTMX
CytomX Therapeutics

Last Price:
$2.22
Seasonality Move:
-17.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

CytomX Therapeutics Stock Forecast

  • Is CytomX Therapeutics Stock Undervalued?
    The current CytomX Therapeutics [CTMX] share price is $2.23. The Score for CTMX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • CTMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will CytomX Therapeutics Stock Go Up Next Year?

Data Unavailable

CytomX Therapeutics Stock Rating

Data Unavailable

CytomX Therapeutics Stock Price History

Is CTMX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTMX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytomx.com

52-Week Data

52-Week High:
2.55
52-Week Low:
0.40

Prediction Charts

Market Cap:
351.3M
Price in USD:
2.23
Volume:
3.1M
Beta:
0.93

Technical Analysis

SMA50:
0.97
SMA100:
0.90
SMA200:
1.02
52-Wk Change:
21.86%

Stock Predictions

  • Is CytomX Therapeutics stock public?
    Yes, CytomX Therapeutics is a publicly traded company.
  • What is the CytomX Therapeutics stock quote today?
    The CytomX Therapeutics stock price is 2.23 USD today.
  • How to buy CytomX Therapeutics stock online?
    You can buy CytomX Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 0.97 0.97 1.04 0.90
May-7 0.96 0.96 1.00 0.92
May-8 0.99 1.09 1.19 0.98
May-9 1.29 0.93 1.30 0.91
May-12 1.90 2.13 2.18 1.65
May-13 2.17 2.50 2.55 1.86
May-14 2.37 2.38 2.38 2.01
May-15 2.50 2.00 2.50 1.87
May-16 2.06 2.03 2.16 1.95
May-19 2.02 2.13 2.25 2.00
May-20 2.14 2.06 2.15 1.97
May-21 2.00 2.04 2.11 1.98
May-22 2.02 2.13 2.23 2.01
May-23 2.06 2.23 2.29 2.03

CytomX Therapeutics Earnings

Data Unavailable

CytomX Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.38 per share.

* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.